Advanced
search

Search results

1 – 9 of 9
View access options
Expert briefing
Publication date: 1 March 2024
Expert Briefings Powered by Oxford Analytica

The vote was lost following Germany’s decision to oppose the directive, which encouraged others to abstain. There are only a few weeks left for the Council to vote again on the…

View access options
Expert briefing
Publication date: 25 March 2020
Expert Briefings Powered by Oxford Analytica

Trump on March 16 ordered social distancing and many businesses’ closure for 15 days, to slow COVID-19’s spread and avoid overwhelming hospitals. Transport, tourism, leisure…

View access options
Expert briefing
Publication date: 22 June 2021
Expert Briefings Powered by Oxford Analytica

Prospects for India to end-2021

Location:
PROSPECTS H2 2021

Prospects H2 2021: India
View access options
Expert briefing
Publication date: 2 July 2021
Expert Briefings Powered by Oxford Analytica

This would require rebuilding bridges with some moderate figures, in order to gain support among the 57 million voters who rejected his party in 2018. However, it also requires a…

Details

DOI: 10.1108/OXAN-DB262518

ISSN: 2633-304X

Keywords

Geographic
Brazil
LA/C
Topical
economy
industry
politics
social
corruption
election
fiscal
government
health
legislation
opposition
party
pharmaceutical
policy
welfare
View access options
Expert briefing
Publication date: 17 August 2016
Expert Briefings Powered by Oxford Analytica

Post-default politics in Puerto Rico.
View access options
Expert briefing
Publication date: 16 March 2016
Expert Briefings Powered by Oxford Analytica

New Zealand's main political parties are divided on TPP ratification, which marks the first such division on a trade agreement in 40 years. The main opposition Labour party has…

View access options
Expert briefing
Publication date: 12 July 2019
Expert Briefings Powered by Oxford Analytica

Trudeau will spend the summer campaigning for re-election, defending his administration’s record while underscoring unfinished business for a second term.
View access options
Expert briefing
Publication date: 21 January 2016
Expert Briefings Powered by Oxford Analytica

The marked increase in 2015 expenses stems in part from Goldman's 5.1-billion-dollar settlement with the Department of Justice (DoJ) and various federal and state regulators…

View access options
Executive summary
Publication date: 11 March 2019
Expert Briefings Powered by Oxford Analytica

UNITED STATES: 2020 budget fight is imminent

Access

Year

Content type

Refine By Country
{"A":[{"count":"2","title":"Australia","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Australia%22"}],"B":[{"count":"1","title":"Belgium","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Belgium%22"},{"count":"1","title":"Brazil","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Brazil%22"}],"C":[{"count":"1","title":"Canada","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Canada%22"},{"count":"3","title":"China","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22China%22"}],"F":[{"count":"1","title":"France","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22France%22"}],"G":[{"count":"1","title":"Germany","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Germany%22"}],"I":[{"count":"1","title":"India","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22India%22"}],"J":[{"count":"1","title":"Japan","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Japan%22"}],"M":[{"count":"2","title":"Mexico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Mexico%22"}],"N":[{"count":"1","title":"New Zealand","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22New+Zealand%22"}],"P":[{"count":"1","title":"Puerto Rico","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22Puerto+Rico%22"}],"U":[{"count":"7","title":"United States","url_remove":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22&p=1","url":"q=%28content-type%3Aoxan-article+OR+content-type%3Aoxan-executive-summary+OR+content-type%3Aoxan-graphic-analysis%29+AND+keyword-topical%3A%22policy%22+AND+keyword-topical%3A%22politics%22+AND+keyword-topical%3A%22industry%22+AND+keyword-topical%3A%22party%22+AND+keyword-topical%3A%22pharmaceutical%22+AND+keyword-topical%3A%22legislation%22+AND+keyword-country%3A%22United+States%22"}]}
1 – 9 of 9
Manage cookies

We’re listening — tell us what you think

Join us on our journey